SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filings

Filing date Form Description Filing Group View
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
POS AM

Post-effective amendment to an S-Type filing

Registration Statements
View HTML
NO ACT

NO ACT

Other
View HTML
NO ACT

NO ACT

Other
View HTML
NO ACT

NO ACT

Other
View HTML
NO ACT

NO ACT

Other
View HTML

Data provided by Kaleidoscope.